Search
Search Menu

Valentina Vengeliene

Valentina obtained a PhD in pharmacology from Heidelberg University in 2005, based on her research done at the Central Institute of Mental Health in Mannheim, Germany. Following her PhD, she continued as a scientist at the Central Institute of Mental Health, focusing on addiction. In particular, …

Read more

Glenn Begley

M.B., B.S., Ph.D., F.R.A.C.P., F.R.C.P.A., F.R.C.Path., F.A.H.M.S. Dr Begley is the inaugural CEO of BioCurate, a joint initiative of Monash and Melbourne Universities and created to provide commercial focus in the early phases of drug development. He served as Chief Scientific Officer at Akriveia Therapeutics, California (2016-2027) …

Read more

Hans Moebius

Hans Moebius, MD, PhD, ECPM, FAAN – is an internationally recognized expert in neuropsychiatry R&D and regulatory strategy with over 30 years of leading R&D positions at Ciba-Geigy, Novartis, Merz, INC Research, TauRx (Singapore), FORUM (USA), CHASE (USA), and Rodin (USA).  During his career, Dr. Moebius has been leading or was closely involved in extensive R&D projects leading to six …

Read more

Dan Deaver

During my academic career I fostered important research collaborations both within and outside the university related to drug development. These efforts required the generation of robust data packages. In the late 1980s, I worked closely with the Upjohn Company during their development of recombinant bovine somatotropin. …

Read more

Rob Miller

Rob Miller has 17 years of biopharma commercial experience with Lilly, Abbott and AbbVie that provides the PAASP US team with an in-depth understanding of how future PAASP biopharma customers develop risk-adjusted valuations for both internal and external innovation:     •New product commercial development and for over …

Read more

Patricia Kabitzke

I obtained my PhD from the City University of New York in Neuroscience, followed by a Postdoctoral fellowship at the Columbia university in New York. During the latter, I completed two projects: 1.) I investigated the neural mechanisms underlying the innate fear response early in life, …

Read more

Andre Der-Avakian

Andre Der-Avakian is Assistant Professor of Psychiatry at the University of California San Diego (UCSD) and Associate Member of the American College of Neuropsychopharmacology (ACNP). He is Principal Investigator on research projects funded by grants from the National Institute of Mental Health (NIMH) and National Institute …

Read more

Prof. Dr. Malcolm Macleod

Malcolm Macleod, BSc(Hons) MBChB PhD FRCP Ed, is Professor of Neurology and Translational Neuroscience at the University of Edinburgh, head of Neurology at Forth Valley Royal Hospital, and Honorary Principal Research Fellow, Florey Neurosciences Unit, Melbourne, Australia.  Prof. Macleod was a founding co-ordinator of the Collaborative …

Read more

Dr. Magali Haas

Magali Haas is CEO and President of Cohen Veterans Bioscience, a non-profit brain research organization based in Cambridge, MA. She previously served as founding Chief Science and Technology Officer for One Mind for Research.  Magali has over 15 years of pharmaceutical executive and clinical research experience, predominantly …

Read more

Dr. Dario Doller

Dario Doller was born, raised and educated in Buenos Aires, Argentina. In 1989, he earned a PhD at the Universidad de Buenos Aires working with Prof. E.G. Gros on the synthesis and spectroscopic properties of steroidal glycoalkaloids from the tomato plant. He took off to College Station, …

Read more

Scroll Up